Litigation Details for Taiho Pharmaceutical Co., Ltd. v. Eugia Pharma Specialities Ltd. (D. Del. 2019)

Taiho Pharmaceutical Co., Ltd. v. Eugia Pharma Specialities Ltd. (D. Del. 2019)

Docket		Date Filed	2019-12-19
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Jennifer L. Hall
Jury Demand	None	Referred To
Parties	AUROBINDO PHARMA LTD.
Patents	10,456,399; 10,457,666; 7,799,783; 9,527,833; RE46,284
Attorneys	Andrew Colin Mayo
Firms	Morris James LLP
Link to Docket	External link to docket

Details for Taiho Pharmaceutical Co., Ltd. v. Eugia Pharma Specialities Ltd. (D. Del. 2019)

Date Filed	Document No.	Description	Snippet	Link To Document
2023-05-04	129	Post Trial Brief	U.S. Patent No. 7,799,783 ’535 patent U.S. Patent No. 6,294,535 … ’284 patent U.S. Patent No. RE46,284 ’783 patent …500 patent’s claims would infringe the earlier patents—that is, whether the patent is a …to the ’284 patent was filed. With that understanding of the ’284 patent in mind, a …at 1378. “A patent has been called a ‘blocking patent’ where practice of a later	External link to document
2023-08-15	139	Opinion - Memorandum Opinion	10,456,399 (the #399 patent). Tr. 473:18-22. He further testified that "you can't apportion…The #284 patent is a reissue of U.S. Patent No. 7,799,783 (the #783 Patent). The #783 patent was filed… #284 patent and U.S. Patent Nos. 9,527,833 (the #833 patent); 10,457,666 (the #666 patent); and 10,456,399…that was in the #783 patent but was not included in the #284 patent. #284 patent at claims 1, 10, 13…testified that U.S. Patent No. 6,479,500 (the #500 patent) was a blocking patent. Tr. 499:24-500:4.	External link to document
2019-12-19	4	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE46,284 E ;10,138,223 B2. (…19 December 2019 1:19-cv-02309 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document